Recent studies concerning driver events in MM strongly suggest that aberrant AID activity, associated with a specific mutational landscape, is mostly involved in the tumor initiation, while later phases of MM development are linked to an APOBEC mutational process [74,75]. This evidence concerns the gene AICDA and Miyoshi myopathy.